Changhoon Yoo

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 55

Top Topics

Locally Advanced

Venous Thromboembolism

Prognostic Factors

Top Venues

Nature medicine

Therapeutic advances in medical oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Changhoon Yoo, Sung Joo Kim, Yoon-Koo Kang
Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Changhoon Yoo, Sung Joo Kim, Yoon-Koo Kang
Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 Plus Imatinib for Advanced Treatment-Refractory Gastrointestinal Stromal Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Young-Gyu Park, Sejin Kim, Kyu-Pyo Kim, Sook-Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Changhoon Yoo
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology international (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors. Future oncology (London, England) 20 (16) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors. Future oncology (London, England) 20 (16) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors. Future oncology (London, England) (2024)
Hyung-Don Kim, Young-Gyu Park, Sejin Kim, Kyu-Pyo Kim, Sook-Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Changhoon Yoo
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology international 18 (3) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Hyung-Don Kim, Young-Gyu Park, Sejin Kim, Kyu-Pyo Kim, Sook-Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Changhoon Yoo
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology international 18 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine (2024)
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors. Future oncology (London, England) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine (2024)
Yeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, Hyung-Don Kim, Kyu-Pyo Kim, Jae Ho Jung, Inkeun Park, Baek-Yeol Ryoo, Dong Ki Lee, Hye Jin Choi, Taek Chung, Seung Hyuck Jeon, Eui-Cheol Shin, Chiyoon Oum, Seulki Kim, Yoojoo Lim, Gahee Park, Chang Ho Ahn, Tae-Bum Lee, Richard S Finn, Chan-Young Ock, Jinho Shin, Changhoon Yoo
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in biliary tract cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-Pyo Kim, Yong Sang Hong, Tae Won Kim, Jin-Sook Ryu, Yong-Il Kim, Changhoon Yoo
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea. Targeted oncology 19 (1) (2023)
Yeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-Pyo Kim, Yong Sang Hong, Tae Won Kim, Jin-Sook Ryu, Yong-Il Kim, Changhoon Yoo
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea. Targeted oncology 19 (1) (2023)
Yeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-Pyo Kim, Yong Sang Hong, Tae Won Kim, Jin-Sook Ryu, Yong-Il Kim, Changhoon Yoo
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea. Targeted oncology 19 (1) (2023)
Hyung-Don Kim, Changhoon Yoo, Min-Hee Ryu, Yoon-Koo Kang
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours. British journal of cancer (2023)
Yeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-Pyo Kim, Yong Sang Hong, Tae Won Kim, Jin-Sook Ryu, Yong-Il Kim, Changhoon Yoo
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea. Targeted oncology (2023)
Hyehyun Jeong, Kyu-Pyo Kim, Jae Ho Jung, Dae Wook Hwang, Jae-Hoon Lee, Ki Hun Kim, Deok Bog Moon, Myung Ah Lee, Se Jun Park, Hong Jae Chon, Jin-Hong Park, Ji Sung Lee, Baek-Yeol Ryoo, Changhoon Yoo
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial. Hepatology (Baltimore, Md.) 77 (5) (2023)
Yeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-Pyo Kim, Yong Sang Hong, Tae Won Kim, Jin-Sook Ryu, Yong-Il Kim, Changhoon Yoo
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea. Targeted oncology 19 (1) (2023)
Young Seob Shin, Hee Hyun Park, Jin-Hong Park, Dong-Wan Seo, Sang Soo Lee, Changhoon Yoo, Seon Ok Kim, Sang Min Yoon, Jinhong Jung, Myung-Hwan Kim, Sung Koo Lee, Do Hyun Park, Tae Jun Song, Dongwook Oh, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-Pyo Kim, Jae Ho Jeong, Jong Hoon Kim
Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis. Cancers 14 (5) (2022)
Kyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, Massimo Iavarone, Min-Hee Ryu, Sook Ryun Park, Hyung-Don Kim, Young-In Yoon, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Shin Hwang, Ki-Hun Kim, Gi-Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L Chan, Massimo De Giorgio, Baek-Yeol Ryoo, Sung-Gyu Lee
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer medicine 12 (3) (2022)
Eun-Joo Park, Hyo-Jung Park, Kyung-Won Kim, Chong-Hyun Suh, Changhoon Yoo, Young-Kwang Chae, Sree Harsha Tirumani, Nikhil H Ramaiya
Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Cancers 14 (3) (2022)
Jwa Hoon Kim, Changhoon Yoo, Seyoung Seo, Jae Ho Jeong, Baek-Yeol Ryoo, Kyu-Pyo Kim, Jung Bok Lee, Keun-Wook Lee, Ji-Won Kim, Il-Hwan Kim, Myoungjoo Kang, Hae Won Ryu, Jaekyung Cheon, Sook Ryun Park
A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY. Cancers 14 (3) (2022)
Kyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, Massimo Iavarone, Min-Hee Ryu, Sook Ryun Park, Hyung-Don Kim, Young-In Yoon, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Shin Hwang, Ki-Hun Kim, Gi-Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L Chan, Massimo De Giorgio, Baek-Yeol Ryoo, Sung-Gyu Lee
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer medicine 12 (3) (2022)
Kyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, Massimo Iavarone, Min-Hee Ryu, Sook Ryun Park, Hyung-Don Kim, Young-In Yoon, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Shin Hwang, Ki-Hun Kim, Gi-Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L Chan, Massimo De Giorgio, Baek-Yeol Ryoo, Sung-Gyu Lee
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer medicine 12 (3) (2022)
Kyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, Massimo Iavarone, Min-Hee Ryu, Sook Ryun Park, Hyung-Don Kim, Young-In Yoon, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Shin Hwang, Ki-Hun Kim, Gi-Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L Chan, Massimo De Giorgio, Baek-Yeol Ryoo, Sung-Gyu Lee
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer medicine 12 (3) (2022)
Dong-Hoon Lim, Stefano Cascinu, Myung Ah Lee, Sara Lonardi, Jin Won Kim, Gianluca Masi, Hong Jae Chon, Margherita Rimini, Ilhwan Kim, Jaekyung Cheon, Jun-Eul Hwang, Jung Hun Kang, Ho Yeong Lim, Changhoon Yoo
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib. Future oncology (London, England) 18 (27) (2022)
Yeong Hak Bang, Choong-Kun Lee, Changhoon Yoo, Hong Jae Chon, Moonki Hong, Beodeul Kang, Hyung-Don Kim, Sook Ryun Park, Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Min-Hee Ryu, Baek-Yeol Ryoo
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis. Therapeutic advances in medical oncology 14 (2022)
Sadahisa Ogasawara, Su-Pin Choo, Jiang-Tao Li, Changhoon Yoo, Bruce Wang, Dee Lee, Pierce K H Chow
Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion. Cancers 13 (11) (2021)
Eo-Jin Kim, Changhoon Yoo, Hyo Jeong Kang, Kyu-Pyo Kim, Min-Hee Ryu, Sook Ryun Park, Danbi Lee, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Baek-Yeol Ryoo
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Hyung-Don Kim, Seongju Jeong, Seongyeol Park, Yong Joon Lee, Young Seok Ju, Danbee Kim, Gi-Won Song, Jae Hoon Lee, Sang-Yeob Kim, Jaehoon Shin, Eui-Cheol Shin, Shin Hwang, Changhoon Yoo, Su-Hyung Park
Implication of CD69+ CD103+ tissue-resident-like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver 41 (4) (2021)
Hyehyun Jeong, Jae Ho Jeong, Kyu-Pyo Kim, Sang Soo Lee, Dong Wook Oh, Do Hyun Park, Tae Jun Song, Yangsoon Park, Seung-Mo Hong, Baek-Yeol Ryoo, Changhoon Yoo
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin. Cancers 13 (2) (2021)
Changhoon Yoo, Sang-Hyun Shin, Joon-Oh Park, Kyu-Pyo Kim, Jae Ho Jeong, Baek-Yeol Ryoo, Woo Hyung Lee, Ki-Byung Song, Dae-Wook Hwang, Jin-Hong Park, Jae-Hoon Lee
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review. Cancers 13 (7) (2021)
Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-Pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy. Therapeutic advances in medical oncology 13 (2021)
Changhoon Yoo, Seonggyu Byeon, Yeonghak Bang, Jaekyung Cheon, Jin W Kim, Jee H Kim, Hong J Chon, Beodeul Kang, Myoung J Kang, Ilhwan Kim, Jun-Eul Hwang, Jung H Kang, Myung A Lee, Jung Y Hong, Ho Y Lim, Baek-Yeol Ryoo
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events. Liver international : official journal of the International Association for the Study of the Liver 40 (9) (2020)
Won Jae Yoon, Yul Oh, Changhoon Yoo, Sunguk Jang, Seong-Sik Cho, Jeong-Hun Suh, Seong-Soo Choi, Do Hyun Park
EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. Journal of clinical medicine 9 (6) (2020)
Changhoon Yoo, Inhwan Hwang, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jae Ho Byun, Jin-Hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Heung-Moon Chang, Kyu-Pyo Kim, Song Cheol Kim, Baek-Yeol Ryoo
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma. Therapeutic advances in medical oncology 12 (2020)
Woohyung Lee, Ye Jong Park, Jae Woo Kwon, Eunsung Jun, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-Pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo, Seo Young Park, Song Cheol Kim
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer. Journal of clinical medicine 9 (5) (2020)
Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Changhoon Yoo, Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Jonggi Choi
Effectiveness and Safety of Nivolumab in Child-Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study. Cancers 12 (7) (2020)
Heejung Chae, Hyehyun Jeong, Jaekyung Cheon, Hong Jae Chon, Hyewon Ryu, Il-Hwan Kim, Myoung Joo Kang, Jae Ho Jeong, Baek-Yeol Ryoo, Kyu-Pyo Kim, Changhoon Yoo
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis. Therapeutic advances in medical oncology 12 (2020)
Hyung-Don Kim, Yeonghak Bang, Myung Ah Lee, Jin Won Kim, Jee Hyun Kim, Hong Jae Chon, Beodeul Kang, Myoung Joo Kang, Ilhwan Kim, Jaekyung Cheon, Jun-Eul Hwang, Jung Hun Kang, Seonggyu Byeon, Jung Yong Hong, Baek-Yeol Ryoo, Ho Yeong Lim, Changhoon Yoo
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Dong Wook Kim, Seung Soo Lee, Seon-Ok Kim, Jin Hee Kim, Hyoung Jung Kim, Jae Ho Byun, Changhoon Yoo, Kyu-Pyo Kim, Ki-Byung Song, Song Cheol Kim
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score. Radiology 296 (3) (2020)
Changhoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, Do-Youn Oh, Kyung-Hun Lee, Hong Jae Chon, Joo Hoon Kim, Myoungjoo Kang, Ilhwan Kim, Guk Jin Lee, Sung Yong Oh, Younak Choi, Hye Jin Choi, Seung Tae Kim, Joon Oh Park, Baek-Yeol Ryoo
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group. Therapeutic advances in medical oncology 11 (2019)
Inhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, Jae Ho Jeong, Kyu-Pyo Kim, Heung-Moon Chang, Changhoon Yoo, Baek-Yeol Ryoo
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores. Investigational new drugs 37 (3) (2018)
Changhoon Yoo, Joong-Won Park, Yoon Jun Kim, Do Young Kim, Su Jong Yu, Tae Seop Lim, Su Jin Lee, Baek-Yeol Ryoo, Ho Yeong Lim
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma. Investigational new drugs 37 (3) (2018)